Explorer
Dcgi
Health
DCGI Approves Serum Institute's Covovax Covid Vaccine For 7-11 Age Group: Report
Health
DCGI Recommends Emergency Use Authorisation To SII's Covovax For Children Aged 7-11 Years
Health
Govt Panel Gives Nod To Serum Institute's qHPV Vaccine For Cervical Cancer Patients Aged 9-26 Yrs
India
Bharat Biotech Asked For More Data By DCGI For Authorising Covaxin To Children Under 12
Health
COVID Vaccine: Govt Panel Recommends Permission For Phase-3 Trial Of Covovax As Booster Dose In Adults
Health
EXPLAINED: Biological E's Corbevax Approved For 12-18 Age Group. Here Is How The Vaccine Works
Health
Biological E's Covid Vaccine Corbevax Gets Emergency Nod For Children Aged 12-18 Years
Health
COVID Vaccine: Single-Dose Sputnik Light Gets DCGI Nod For Emergency Use In India
India
Covishield, Covaxin Granted Regular Market Approval For Use In Adult Population
India
Prices Of Covishield, Covaxin Likely To Be Capped At Rs 275 After Regular Market Approval
Health
Govt Panel Recommends Regular Market Approval For Covishield And Covaxin
Health
DCGI Gives Nod To Bharat Biotech's Intranasal Covid Vaccine For Phase 3 'Booster Dose Study'
Advertisement
Advertisement
Top Headlines
Election 2025
Curtains Fall On Second Phase Of Bihar Polls; NDA, Mahagathbandhan Make Last Push: Top Updates
India
Tharoor Hails Advani As ‘True Statesman’, Draws Parallel With Nehru And Indira; Congress Reacts
India
Are Muslims Allowed To Be Part Of RSS? Mohan Bhagwat Replies: 'Can Come To Sangh If...'
Cities
Students, Delhi Residents Protesting Against Delhi's Air Pollution Detained By Police
